Commit To Buy Regulus Therapeutics At $2.50, Earn 25.3% Annualized Using Options
September 26, 2016 at 11:43 AM EDT
Investors eyeing a purchase of Regulus Therapeutics Inc (RGLS) shares, but tentative about paying the going market price of $3.36/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2017 put at the $2.50 strike, which has a bid at the time of this writing of 25 cents..